ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
200326-100MG |
|
NA |
1,?1,?1-?Trifluoro-?N-?[(6S)?-?6-?oxido-?4,?8-di(9-anthracenyl)dibenzo[d,f][1,3,2]dioxaphosphepin-?6-?yl]?methanesulfonamide ≥95%,99%e.e. |
100MG | C45H33F3NO5PS | |
200325-100MG |
|
NA |
1,?1,?1-?Trifluoro-?N-?[(6R)?-?6-?oxido-?4,?8-di(9-anthracenyl)dibenzo[d,f][1,3,2]dioxaphosphepin-?6-?yl]?methanesulfonamide ≥95%,99%e.e. |
100MG | C45H33F3NO5PS | |
200324-100MG |
|
NA |
1,?1,?1-?Trifluoro-?N-?[(6S)?-?6-?oxido-?4,?8-di(1-naphthalenyl)dibenzo[d,f][1,3,2]dioxaphosphepin-?6-?yl]?methanesulfonamide ≥95%,99%e.e. |
100MG | C37H29F3NO5PS | |
200323-100MG |
|
NA |
1,?1,?1-?Trifluoro-?N-?[(6R)?-?6-?oxido-?4,?8-di(1-naphthalenyl)dibenzo[d,f][1,3,2]dioxaphosphepin-?6-?yl]?methanesulfonamide ≥95%,99%e.e. |
100MG | C37H29F3NO5PS | |
200322-100MG |
|
NA |
1,?1,?1-?Trifluoro-?N-?[(6S)?-?6-?oxido-?4,?8-bis(2,4,6-trimethylphenyl)dibenzo[d,f][1,3,2]dioxaphosphepin-?6-?yl]?methanesulfonamide ≥95%,99%e.e. |
100MG | C35H37F3NO5PS | |
200321-100MG |
|
NA |
1,?1,?1-?Trifluoro-?N-?[(6R)?-?6-?oxido-?4,?8-bis(2,4,6-trimethylphenyl)dibenzo[d,f][1,3,2]dioxaphosphepin-?6-?yl]?methanesulfonamide ≥95%,99%e.e. |
100MG | C35H37F3NO5PS | |
200320-100MG |
|
NA |
1,?1,?1-?Trifluoro-?N-?[(6S)?-?6-?oxido-?4,?8-bis[4-(tert-butyl)phenyl]dibenzo[d,f][1,3,2]dioxaphosphepin-?6-?yl]?methanesulfonamide ≥95%,99%e.e. |
100MG | C37H41F3NO5PS | |
200319-100MG |
|
NA |
1,?1,?1-?Trifluoro-?N-?[(6R)?-?6-?oxido-?4,?8-bis[4-(tert-butyl)phenyl]dibenzo[d,f][1,3,2]dioxaphosphepin-?6-?yl]?methanesulfonamide ≥95%,99%e.e. |
100MG | C37H41F3NO5PS | |
200229-50MG |
|
NA |
1,?1,?1-?Trifluoro-?N-?[(11aS)?-?10,?11,?12,?13-?tetrahydro-?5-?oxido-?3,?7-?bis[3,5-bis(tert-butyl)-4-methoxyphenyl]?diindeno[7,?1-?de:1',?7'-?fg]?[1,?3,?2]?dioxaphosphocin-?5-?yl]?methanesulfonamide ≥98%,99%e.e |
50MG | C48H59F3NO7PS | |
200228-50MG |
|
NA |
1,?1,?1-?Trifluoro-?N-?[(11aR)?-?10,?11,?12,?13-?tetrahydro-?5-?oxido-?3,?7-?bis[3,5-bis(tert-butyl)-4-methoxyphenyl]?diindeno[7,?1-?de:1',?7'-?fg]?[1,?3,?2]?dioxaphosphocin-?5-?yl]?methanesulfonamide ≥98%,99%e.e |
50MG | C48H59F3NO7PS | |
200091-100MG |
|
1227374-64-2 |
N-?[(11bS)?-?2,?6-?Di-?9-?anthracenyl-?8,?9,?10,?11,?12,?13,?14,?15-?octahydro-?8-?oxidodinaphtho[2,?1-?d:1',?2'-?f]?[1,?3,?2]?dioxaphosphepin-?4-?yl]?-?1,?1,?1-?trifluoromethanesulfonamide ≥98%,99%e.e. |
100MG | C49H37F3NO5PS | |
200090-100MG |
|
1227374-65-3 |
N-?[(11bR)?-?2,?6-?Di-?9-?anthracenyl-?8,?9,?10,?11,?12,?13,?14,?15-?octahydro-?8-?oxidodinaphtho[2,?1-?d:1',?2'-?f]?[1,?3,?2]?dioxaphosphepin-?4-?yl]?-?1,?1,?1-?trifluoromethanesulfonamide ≥98%,- |
100MG | C49H37F3NO5PS | |
200053-50MG |
|
NA |
1,?1,?1-?Trifluoro-?N-?[(11aS)?-?10,?11,?12,?13-?tetrahydro-?5-?oxido-?3,?7-?bis(triphenylsilyl)diindeno[7,?1-?de:1',?7'-?fg]?[1,?3,?2]?dioxaphosphocin-?5-?yl]?methanesulfonamide ≥98%,99%e.e. |
50MG | C54H43F3NO5PSSi2 | |
200052-50MG |
|
NA |
1,?1,?1-?Trifluoro-?N-?[(11aR)?-?10,?11,?12,?13-?tetrahydro-?5-?oxido-?3,?7-?bis(triphenylsilyl)diindeno[7,?1-?de:1',?7'-?fg]?[1,?3,?2]?dioxaphosphocin-?5-?yl]?methanesulfonamide ≥98%,99%e.e. |
50MG | C54H43F3NO5PSSi2 | |
200051-50MG |
|
1424201-66-0 |
1,?1,?1-?Trifluoro-?N-?[(11aS)?-?10,?11,?12,?13-?tetrahydro-?5-?oxido-?3,?7-?bis(2,?4,?6-?trisisopropylphenyl)diindeno[7,?1-?de:1',?7'-?fg]?[1,?3,?2]?dioxaphosphocin-?5-?yl]?methanesulfonamide ≥98%,99%e.e. |
50MG | C48H59F3NO5PS | |
200050-50MG |
|
NA |
1,?1,?1-?Trifluoro-?N-?[(11aR)?-?10,?11,?12,?13-?tetrahydro-?5-?oxido-?3,?7-?bis(2,?4,?6-?trisisopropylphenyl)?diindeno[7,?1-?de:1',?7'-?fg]?[1,?3,?2]?dioxaphosphocin-?5-?yl]?methanesulfonamide ≥98%,99%e.e. |
50MG | C48H59F3NO5PS | |
200049-50MG |
|
NA |
1,?1,?1-?Trifluoro-?N-?[(11aS)?-?10,?11,?12,?13-?tetrahydro-?3,?7-?di-9-anthracenyl-?5-?oxido-diindeno[7,?1-?de:1',?7'-?fg]?[1,?3,?2]?dioxaphosphocin-?5-?yl]?methanesulfonamide ≥98%,99%e.e. |
50MG | C46H31F3NO5PS | |
200048-50MG |
|
NA |
1,?1,?1-?Trifluoro-?N-?[(11aR)?-?10,?11,?12,?13-?tetrahydro-?3,?7-?di-9-anthracenyl-?5-?oxido-diindeno[7,?1-?de:1',?7'-?fg]?[1,?3,?2]?dioxaphosphocin-?5-?yl]?methanesulfonamide ≥98%,99%e.e. |
50MG | C46H31F3NO5PS | |
200047-100MG |
|
NA |
1,?1,?1-?Trifluoro-?N-?[(11aS)?-?10,?11,?12,?13-?tetrahydro-?3,?7-?diphenyl-?5-?oxido-diindeno[7,?1-?de:1',?7'-?fg]?[1,?3,?2]?dioxaphosphocin-?5-?yl]?methanesulfonamide ≥98%,- |
100MG | C30H23F3NO5PS | |
200046-100MG |
|
NA |
1,?1,?1-?Trifluoro-?N-?[(11aR)?-?10,?11,?12,?13-?tetrahydro-?3,?7-?diphenyl-?5-?oxido-diindeno[7,?1-?de:1',?7'-?fg]?[1,?3,?2]?dioxaphosphocin-?5-?yl]?methanesulfonamide ≥98%,- |
100MG | C30H23F3NO5PS | |